KCT0007442尚未招募未知
Prospective, multicenter, open-labeled, phase II study of clinical effect of the combination of metformin and standard chemotherapy in patient with newly diagnosed with T-cell lymphoma and the role of AMP-activated protein kinase (AMPK)
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 70(Year)（—）
- 性别
- All
入选标准
- •not applicable
排除标准
- •not applicable
研究者
相似试验
进行中（未招募）
不适用
A phase II, open-label, prospective, multicenter study to evaluate theefficacy and safety of subsequent treatment with the Zevalin(ibritumomab tiuxetan) study in patients with follicular grade I-IIlymphoma after 4 cycles of Fludarabine-Mitoxantrone-Rituximab(FMR) therapy. - NDEUCTR2006-004850-26-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
进行中（未招募）
1 期
A phase II, multicentre, open label, prospective, interventional study to evaluate the sperm DNA fragmentation in idiopathic male infertility before and after treatment with Gonal-f PEN 900 IU. - NDIdiophatic male infertilityMedDRA version: 9.1Level: SOCClassification code 10014698EUCTR2010-020196-23-ITMERCK SERONO SPA
进行中（未招募）
1 期
A study evaluating the safety and efficacy of the combination of tirabrutinib (GS-4059) and entospletinib with and without obinutuzumab in subjects with chronic lymphocytic leukemiaAdults with relapsed or refractory chronic lymphocytic leukemiaMedDRA version: 20.1Level: LLTClassification code 10008976Term: Chronic lymphocytic leukemiaSystem Organ Class: 100000004864EUCTR2016-002768-15-DEGilead Sciences, Inc.36
进行中（未招募）
1 期
A study evaluating the safety and efficacy of the combination of tirabrutinib (GS-4059) and idelalisib with and without obinutuzumab in subjects with chronic lymphocytic leukemiaEUCTR2015-003909-42-DEGilead Sciences, Inc.36
进行中（未招募）
不适用
Prospective, open label, multi center phase II clinical trial with neoadjuvant chemotherapy in addition with Sorafenib in patients with primarily advanced ovarian cancer (FIGO IIIC + IV) and ascites (>500ml) - primofenib-07Stage FIGO IIIc and IV with more than 500 ml ascitesMedDRA version: 9.1Level: LLTClassification code 10057529Term: Ovarian cancer metastaticOvarian CancerEUCTR2006-004644-24-DEniversity of Bonn102